Tryptophan

Tryptophan

SCHEMBL6032938

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.80
KDM4E B2RXH2 3/20 0.80
MAPT P10636 3/20 0.80
LMNA P02545 2/20 0.80
TSHR P16473 2/20 0.80
BLM P54132 2/20 0.80
PMP22 Q01453 2/20 0.80
MEN1 O00255 2/20 0.80
MPO P05164 1/20 0.80
HIF1A Q16665 1/20 0.80
HTR1A P08908 2/20 0.67
HTR2A P28223 2/20 0.67
HTR2C P28335 2/20 0.67
SLC6A4 P31645 2/20 0.67
HTR7 P34969 2/20 0.67
HTR2B P41595 2/20 0.67
ALDH1A1 P00352 1/20 0.67
CYP3A4 P08684 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
ALOX15 P16050 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL27153674 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL243573 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
D-Tryptophan SCHEMBL10359011 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
D-Tryptophan SCHEMBL10359012 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL15168746 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL243574 1.00 KMT2A (0.80) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL152717 0.99 KMT2A (0.78) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL325026 0.99 KMT2A (0.78) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL27561249 0.99 KMT2A (0.78) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL9449482 0.95 KDM4E (0.73) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982246-B1 Cytomodulating peptide for inhibiting lymphocyte activity SANGSTAT MEDICAL CORPORATION (US) 2006-01-03 US disclosed
US-6982246-B1 Cytomodulating peptide for inhibiting lymphocyte activity SANGSTAT MEDICAL CORPORATION (US) 2006-01-03 US disclosed
US-6162434-A Cytomodulating peptide for inhibiting lymphocyte activity SANGSTAT MEDICAL CORPORATION (US) 2000-12-19 US disclosed
US-6162434-A Cytomodulating peptide for inhibiting lymphocyte activity SANGSTAT MEDICAL CORPORATION (US) 2000-12-19 US disclosed